Refreshments

May 10, 2022
Latest in Clinical News
Fatigue is one of the most common and debilitating symptoms of Long COVID.
Multi-organ MRI shows no added benefit in major UK Long COVID trial
August 4, 2026
Logiq e X
GE HealthCare launches Logiq e compact ultrasound system family
August 4, 2026
Lung Cancer Stages 400
Europe’s lung screening training gaps sharpen focus on implementation
August 3, 2026
Acquisitions
RevealDx secures distribution deal, $3.4M investment from 4DMedical
August 3, 2026
Related Stories
2019 09 17 16 01 9179 Accuray Astro 2019
Clinical News
Accuray touts ESTRO 2022 research presentations
2019 09 17 16 42 0082 Viewray Astro 2019
Clinical News
ViewRay highlights presentation at ESTRO 2022
2020 02 05 19 40 5727 Agfa Rsna 2019 400
Industry News
Agfa posts mixed results in Q1
2022 05 10 18 21 1076 2022 05 10 Ismrm Mr Fingerprinting 400
Conference
Can machine learning deliver 1-minute brain MRI scans?
More in Clinical News
Multi-organ MRI shows no added benefit in major UK Long COVID trial
By Claudia Tschabuschnig
A major UK trial found no benefit from routinely adding multi-organ MRI to specialist Long COVID care. Abnormalities were detected, but fatigue and quality of life did not improve.
August 4, 2026
Fatigue is one of the most common and debilitating symptoms of Long COVID.
GE HealthCare launches Logiq e compact ultrasound system family
By AuntMinnie.com staff writers
The Logiq e X and Logiq e S systems are designed for point-of-care use across a variety of clinical settings.
August 4, 2026
Logiq e X
Europe’s lung screening training gaps sharpen focus on implementation
By Claudia Tschabuschnig
A new SOLACE survey reveals wide variation in lung cancer screening training across Europe, underscoring the need for harmonized standards and coordinated care pathways.
August 3, 2026
Lung Cancer Stages 400
RevealDx secures distribution deal, $3.4M investment from 4DMedical
By AuntMinnie.com staff writers
Under the agreement, 4DMedical will distribute RevealAI-Lung in the U.S., Europe, Australia, and New Zealand.
August 3, 2026
Acquisitions
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
By Claudia Tschabuschnig
A Dutch study found that adding metabolic imaging to contrast-enhanced CT improved early detection of local tumor progression after liver ablation or resection, including disease missed by CT alone.
July 30, 2026
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
Median Technologies signs Canon Medical partnership for eyonis LCS
By AuntMinnie.com staff writers
Canon's subsidiary Olea Medical will leverage its CT imaging platform to support distribution of Median's software.
July 30, 2026
Business Handshake Intelligence 400 (1)
Scottish team designs 10-year sustainability model for preclinical imaging
By Claudia Tschabuschnig
A Scottish team has designed a theoretical 10-year strategy for keeping a multimodal preclinical imaging facility financially viable, operationally resilient, environmentally responsible, and accessible to researchers.
July 29, 2026
Pexels Thirdman 8940356 (1)
ESMI review maps cancer biology ahead of TOPIM 2026
By Claudia Tschabuschnig
Ahead of TOPIM 2026, a new Nature Reviews Cancer article explores how molecular imaging can reveal the biological processes driving tumor growth, resistance, and immune evasion.
July 28, 2026
Overview of the hallmarks of cancer and the imaging modalitites that are being used to assess them.
ITM launches new oncology therapeutics division
By AuntMinnie.com staff writers
Lumara Bio will focus resources toward commercial readiness for ITM's lead drug candidate, lutetium-177 (Lu-177) edotreotide (ITM-11).
July 27, 2026
Lumara
Societies host events for MR Safety Week
By AuntMinnie.com staff writers
Observances trace to the 2001 death of Michael Colombini.
July 27, 2026
Safety
SPECT/CT viable over PET/CT for high-risk prostate cancer staging
By Will Morton
Considering its broader accessibility, Tc-99m MIP-1404 CZT SPECT/CT may represent a practical alternative for primary staging.
July 24, 2026
Maximum intensity projection of Ga-68 PSMA-11 PET/CE-CT (A), Tc-99m MIP-1404 CZT SPECT/CT (B) and Tc-99m HDP CZT SPECT/CT (C) imaging. Ga-68 PSMA-11 PET/CE-CT and Tc-99m MIP-1404 CZT SPECT/CT showing tracer uptake in lymph nodes below the iliac bifurcation and above, paraaortic and left supraclavicular, bone uptake in the right proximal femur and right scapula (arrows). Tc-99m HDP CZT SPECT/CT did not show any uptake suspicious for metastatic disease. No sclerotic lesions suspicious of metastases were detected by the CT component in any of the studies. Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (D) and Tc-99m MIP-1404 CZT SPECT/CT (E) showing uptake in lymph nodes in the left pelvic area below the iliac bifurcation (arrows). Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (F) and Tc-99m MIP-1404 CZT SPECT/CT (G) showing uptake in the right proximal femur, not detected by Tc-99m HDP CZT SPECT/CT (H), (arrows).
Wellumio nabs $9.75M for portable stroke imaging device
By AuntMinnie.com staff writers
Axana is a portable, battery-powered brain imaging device that delivers MRI-based stroke assessment at the point of care.
July 23, 2026
Wellumio co-founders Dr Shieak Tzeng and Dr Sergei Obruchkov with the Axana portable stroke detection device.
Page 1 of 1328
Next Page